Hussman Strategic Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-126,000	Closed	-$3.26M	–	318
2025 Q4	$3.26M	Buy	126,000 +21,000	+20%	+$499K	0.79%	16
2025 Q3	$2.71M	Buy	+105,000	New	+$2.58M	0.59%	48
2024 Q4	–	Sell	-21,000	Closed	-$316K	–	290
2024 Q3	$316K	Hold	21,000	–	–	0.08%	181
2024 Q2	$601K	Hold	21,000	–	–	0.17%	181
2024 Q1	$614K	Hold	21,000	–	–	0.14%	175
2023 Q4	$709K	Sell	21,000 -5,000	-19%	-$146K	0.16%	172
2023 Q3	$798K	Hold	26,000	–	–	0.15%	222
2023 Q2	$1.04M	Sell	26,000 -20,800	-44%	-$860K	0.19%	211
2023 Q1	$1.91M	Hold	46,800	–	–	0.3%	138
2022 Q4	$1.81M	Buy	+46,800	New	+$2.28M	0.29%	138
2022 Q1	–	Sell	-5,200	Closed	-$313K	–	345
2021 Q4	$313K	Sell	5,200 -1,000	-16%	-$55.1K	0.07%	277
2021 Q3	$347K	Sell	6,200 -6,200	-50%	-$357K	0.08%	269
2021 Q2	$752K	Buy	+12,400	New	+$785K	0.16%	224